JPH0358330B2 - - Google Patents
Info
- Publication number
- JPH0358330B2 JPH0358330B2 JP58132782A JP13278283A JPH0358330B2 JP H0358330 B2 JPH0358330 B2 JP H0358330B2 JP 58132782 A JP58132782 A JP 58132782A JP 13278283 A JP13278283 A JP 13278283A JP H0358330 B2 JPH0358330 B2 JP H0358330B2
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- drug
- saiko
- toxohormone
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 claims description 27
- 229940079593 drug Drugs 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 206010028980 Neoplasm Diseases 0.000 claims description 10
- 201000011510 cancer Diseases 0.000 claims description 10
- 241001061264 Astragalus Species 0.000 claims description 9
- 235000006533 astragalus Nutrition 0.000 claims description 9
- 210000004233 talus Anatomy 0.000 claims description 9
- 241000411851 herbal medicine Species 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 7
- 208000024891 symptom Diseases 0.000 claims description 7
- 244000000626 Daucus carota Species 0.000 claims description 5
- 235000002767 Daucus carota Nutrition 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 5
- 229940010454 licorice Drugs 0.000 claims description 5
- 230000004130 lipolysis Effects 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 4
- 206010061428 decreased appetite Diseases 0.000 claims description 4
- 240000002045 Guettarda speciosa Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 208000022531 anorexia Diseases 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000002366 lipolytic effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 230000037356 lipid metabolism Effects 0.000 claims description 2
- 239000003053 toxin Substances 0.000 claims description 2
- 231100000765 toxin Toxicity 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 231100000614 poison Toxicity 0.000 claims 1
- 230000007096 poisonous effect Effects 0.000 claims 1
- 206010003445 Ascites Diseases 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 201000007270 liver cancer Diseases 0.000 description 5
- 208000014018 liver neoplasm Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 244000184734 Pyrus japonica Species 0.000 description 4
- 230000004596 appetite loss Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 244000003416 Asparagus officinalis Species 0.000 description 3
- 235000005340 Asparagus officinalis Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 101800000263 Acidic protein Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- -1 aqueous methanol Chemical compound 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58132782A JPS6025933A (ja) | 1983-07-22 | 1983-07-22 | 癌症状改善剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58132782A JPS6025933A (ja) | 1983-07-22 | 1983-07-22 | 癌症状改善剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6025933A JPS6025933A (ja) | 1985-02-08 |
| JPH0358330B2 true JPH0358330B2 (enrdf_load_stackoverflow) | 1991-09-05 |
Family
ID=15089413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58132782A Granted JPS6025933A (ja) | 1983-07-22 | 1983-07-22 | 癌症状改善剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6025933A (enrdf_load_stackoverflow) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100408852B1 (ko) * | 2000-09-29 | 2003-12-06 | 최용주 | 항암 효과가 있는 생약 조성물 |
| AU2002217832A1 (en) * | 2000-11-15 | 2002-05-27 | Rutgers, The State University Of New Jersey | Black tea extract for prevention of disease |
| JP2005008539A (ja) * | 2003-06-17 | 2005-01-13 | Fancl Corp | マトリックスメタロプロテイナーゼ阻害剤 |
| DE202005015707U1 (de) * | 2005-10-06 | 2006-04-20 | Sheng Foong Pharmaceutical Co. Ltd., Su-Ao Chen | Kräuterzusammensetzung zur Behandlung von Krebs |
| AU2009232715B2 (en) * | 2008-03-31 | 2015-07-09 | Shiseido Company Ltd. | Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method |
| CN102688468A (zh) * | 2012-06-13 | 2012-09-26 | 刘宗奎 | 一种治疗女性四肢发凉的中药组方 |
| CN102872237A (zh) * | 2012-08-23 | 2013-01-16 | 李承平 | 一组升麻举陷片 |
| CN103169778B (zh) * | 2013-03-12 | 2015-07-22 | 张成全 | 一种治疗肺癌的药物组合物及其制备方法 |
| EP3342416A1 (de) * | 2016-12-28 | 2018-07-04 | Erber Aktiengesellschaft | Verwendung von wenigstens einem glycyrrhiza-pflanzenpräparats, eines antidos davon sowie verwendung des antidots |
-
1983
- 1983-07-22 JP JP58132782A patent/JPS6025933A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6025933A (ja) | 1985-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0321004B2 (enrdf_load_stackoverflow) | ||
| WO2000054793A1 (en) | Pharmaceutical composition comprising mixed aqueous extract of anemarrhena rhizoma and phellodendron bark for analgesic and anti-inflammation | |
| JPS5936619A (ja) | 制癌補助剤 | |
| JPS60214741A (ja) | 血糖降下剤 | |
| JPH0358330B2 (enrdf_load_stackoverflow) | ||
| JPH04243832A (ja) | 自己免疫疾患治療剤 | |
| CN102579559B (zh) | 一种龙须藤乙酸乙酯提取物、正丁醇提取物及其制备方法和用途 | |
| JPH0256330B2 (enrdf_load_stackoverflow) | ||
| CN103690676A (zh) | 一种治疗脑缺血、脑梗塞的锦灯笼蓿萼总皂苷提取物 | |
| CN103655559B (zh) | 角蒿酯碱类化合物在制备抗乳腺癌药物中的应用 | |
| HU203043B (en) | Process for producing pharmaceutical compositions against tumour and ulcer containing euphorbia hirta l. it's parts or extract | |
| WO1993013787A1 (en) | Immunopotentiating agent | |
| KR0156039B1 (ko) | 제조로부터 의약 추출물을 제조하는 방법 및 그 추출물을 함유하는 간장질환의 예방 및 치료용 의약조성물 | |
| JPS62198621A (ja) | 制癌補助剤 | |
| CN101396435A (zh) | 一种治疗胃病的中药及其制备方法和应用 | |
| CN112089783A (zh) | 中药组合物在制备预防或/和治疗肥胖的药物中的应用 | |
| JPH0643328B2 (ja) | 冠血管拡張剤 | |
| WO1994003193A1 (en) | Remedy for biotoxin type bacterial intestinal infectious diseases | |
| CN105106303B (zh) | 夏枯草水提物的医药用途 | |
| CN105878362A (zh) | 龙胆环烯醚萜总苷在制备治疗肝损伤药物中的用途 | |
| JP2821575B2 (ja) | 肝障害改善剤 | |
| JPS62132829A (ja) | 肝炎の治療剤 | |
| CN104510857B (zh) | 一种用于降脂的中药有效部位组合物及其制剂 | |
| JPH0535131B2 (enrdf_load_stackoverflow) | ||
| CN108976308B (zh) | 辽东楤木根多糖提取物及其制备方法和在肝损伤保护中的用途 |